✦ LIBER ✦

Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer

✍ Scribed by Stephen Chia; William Gradishar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endocrine treatment options for advanced

✍ J.F.R. Robertson; S.E. Come; S.E. Jones; L. Beex; M. Kaufmann; A. Makris; J.W.R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 402 KB

PCN52 ECONOMIC EVALUATION OF FULVESTRANT

✍ D Greenberg; M Rabinovich; M Hirsch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Neoadjuvant endocrine therapy for postme

✍ Hiroji Iwata 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 215 KB

What Is the Optimal Endocrine Therapy fo

✍ Tung, N. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 114 KB

P139 Experience with fulvestrant in the

✍ P. Neven 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

PCN62 COST ANALYSIS OF HORMONE RECEPTOR

✍ E Abdo Filho; M Takemoto; VD Teich; FF Quintella; RA Fernandes; RBF Passos; N Te 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB